Bourne Lent Asset Management’s Eli Lilly LLY Stock Holding History

Bourne Lent Asset Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.58M	Sell	3,887 -10	-0.3%	-$10.1K	1.31%	17
2025 Q4	$4.19M	Sell	3,897 -25	-0.6%	-$23.9K	1.39%	15
2025 Q3	$2.99M	Buy	3,922 +15	+0.4%	+$11.2K	1.06%	18
2025 Q2	$3.05M	Hold	3,907	–	–	1.18%	16
2025 Q1	$3.23M	Hold	3,907	–	–	1.38%	15
2024 Q4	$3.02M	Hold	3,907	–	–	1.15%	16
2024 Q3	$3.46M	Buy	3,907 +19	+0.5%	+$17.1K	1.31%	14
2024 Q2	$3.52M	Buy	3,888 +2	+0.1%	+$1.6K	1.35%	14
2024 Q1	$3.02M	Hold	3,886	–	–	1.22%	15
2023 Q4	$2.27M	Sell	3,886 -20	-0.5%	-$11.7K	0.92%	18
2023 Q3	$2.1M	Sell	3,906 -20	-0.5%	-$10.3K	0.92%	21
2023 Q2	$1.84M	Sell	3,926 -50	-1%	-$21K	0.64%	26
2023 Q1	$1.37M	Sell	3,976 -50	-1%	-$16.9K	0.52%	27
2022 Q4	$1.47M	Hold	4,026	–	–	0.63%	26
2022 Q3	$1.3M	Sell	4,026 -50	-1%	-$15.8K	0.57%	29
2022 Q2	$1.32M	Hold	4,076	–	–	0.52%	29
2022 Q1	$1.17M	Hold	4,076	–	–	0.37%	31
2021 Q4	$1.13M	Hold	4,076	–	–	0.3%	33
2021 Q3	$942K	Hold	4,076	–	–	0.27%	33
2021 Q2	$936K	Hold	4,076	–	–	0.26%	33
2021 Q1	$761K	Hold	4,076	–	–	0.24%	35
2020 Q4	$688K	Sell	4,076 -213	-5%	-$31.8K	0.23%	34
2020 Q3	$635K	Hold	4,289	–	–	0.24%	33
2020 Q2	$704K	Sell	4,289 -964	-18%	-$148K	0.3%	32
2020 Q1	$729K	Hold	5,253	–	–	0.39%	28
2019 Q4	$690K	Hold	5,253	–	–	0.33%	33
2019 Q3	$587K	Hold	5,253	–	–	0.28%	31
2019 Q2	$582K	Hold	5,253	–	–	0.28%	31
2019 Q1	$682K	Hold	5,253	–	–	0.34%	31
2018 Q4	$608K	Hold	5,253	–	–	0.36%	30
2018 Q3	$564K	Hold	5,253	–	–	0.27%	35
2018 Q2	$448K	Hold	5,253	–	–	0.24%	42
2018 Q1	$406K	Hold	5,253	–	–	0.22%	44
2017 Q4	$444K	Buy	5,253 +639	+14%	+$54.4K	0.24%	43
2017 Q3	$395K	Hold	4,614	–	–	0.2%	46
2017 Q2	$380K	Hold	4,614	–	–	0.21%	45
2017 Q1	$388K	Hold	4,614	–	–	0.21%	45
2016 Q4	$339K	Hold	4,614	–	–	0.2%	44
2016 Q3	$370K	Hold	4,614	–	–	0.27%	38
2016 Q2	$363K	Hold	4,614	–	–	0.29%	40
2016 Q1	$332K	Hold	4,614	–	–	0.27%	41
2015 Q4	$389K	Hold	4,614	–	–	0.29%	38
2015 Q3	$386K	Sell	4,614 -900	-16%	-$76K	0.32%	37
2015 Q2	$460K	Hold	5,514	–	–	0.36%	37
2015 Q1	$401K	Buy	+5,514	New	+$393K	0.3%	40

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bourne Lent Asset Management's LLY Position: Q1 2026 in Review

Bourne Lent Asset Management reduced its Eli Lilly (LLY) stake by 0.26% in Q1 2026, selling an estimated $10.1K and leaving 3,887 shares worth $3.58M. The position accounts for 1.31% of the portfolio, ranked #17.

Bourne Lent Asset Management first reported a position in LLY in Q1 2015 and has held it in 45 quarters since. The position peaked at $4.19M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Bourne Lent Asset Management held 3,887 shares of Eli Lilly worth $3.58M as of Q1 2026.
Bourne Lent Asset Management sold 10 Eli Lilly shares in Q1 2026, an estimated $10.1K.
Eli Lilly made up 1.31% of Bourne Lent Asset Management's portfolio in Q1 2026, its #17 holding.
Bourne Lent Asset Management first reported a position in Eli Lilly in Q1 2015 and has held it in 45 quarters since.
Bourne Lent Asset Management's Eli Lilly position peaked at $4.19M in Q4 2025.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Bourne Lent Asset Management's 13F filing for Q1 2026, filed 17 Apr 2026.